Bronchiolitis is a common lower respiratory tract infection in infants and young children, and
respiratory syncytial virus (RSV) is the most common cause of this infection. RSV is …

Respiratory syncytial virus (RSV) infection is ubiquitous with almost all infants having been
infected by 2 years of age and lifelong repeated infections common. It is the second largest …

Objective. Preterm infants, especially those with chronic lung disease (CLD), are considered
more susceptible to severe respiratory illness from respiratory syncytial virus (RSV) infection …

Respiratory syncytial virus (RSV) is an RNA virus that causes respiratory tract infections in
children. In the Northern Hemisphere, the peak infection season is November through April …

2. Although the quest for a safe and effective vaccine remains unsuccessful, the more
vulnerable patients can be protected with passive prophylaxis. Because of limited clinical …

Treatment for infants with bronchiolitis caused by respiratory syncytial virus (RSV) includes
supplemental oxygen, nasal suctioning, fluids to prevent dehydration, and other supportive …

Respiratory syncytial virus (RSV) infects almost all children by two years of age, resulting in
a large number of hospital admissions in infants. Reactive airway disease is more common …

BACKGROUND: Monoclonal antibody to respiratory syncytial virus (RSV; palivizumab) is
recommend for prophylaxis of high-risk infants during bronchiolitis seasons but not for RSV …

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract
infections in infants and young children, accounting for more than 100,000 hospitalizations …

BACKGROUND: The trends in hospitalization rates and risk factors for severe bronchiolitis
have not been recently described, especially after the routine implementation of prophylaxis …